Meridian Bioscience (VIVO)
Meridian Bioscience News
1 Great Dividend You Can Buy Right Now
Fool about 15 days agoThis stock has a dividend you can count on.
Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Profit Margin
Benzinga about 19 days agoMERIDIAN BIOSCIENCE INC Files SEC form 10-Q, Quarterly Report
about 23 days ago2 High-Yield Dividend Stocks To Avoid
Seeking Alpha about 30 days ago2 High-Yield Dividend Stocks To Avoid
MERIDIAN BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
about 32 days agoMeridian Bioscience Beats on Both Top and Bottom Lines
about 33 days agoMeridian Bioscience earnings jump in 2Q
about 37 days agoMeridian Bioscience, Inc. (VIVO) Declares $0.19 Quarterly Dividend; 4% Yield
Street Insider about 37 days agoMeridian Bioscience, Inc. (VIVO) Tops Q2 EPS by 2c; Reaffirms Outlook
Street Insider about 37 days agoMeridian Bioscience Reports Record Second Quarter and First Six Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2012 Guidance
Business Wire about 37 days agoMeridian Bioscience, Inc. :
Q2 2012 Meridian Bioscience, Inc. Earnings Release - Before Market Open
about 37 days agoCanaccord Genuity Reiterates a 'Buy' on Meridian Biosciences (VIVO); Positive Meeting With Management
Street Insider about 47 days agoMeridian Bioscience Awarded New Agreement with Premier Healthcare Alliance for Molecular Diagnostic Tests and Instruments for C
Benzinga about 51 days agoMeridian Bioscience Awarded New Agreement with Premier Healthcare Alliance for Molecular Diagnostic Tests and Instruments for C. difficile and Group B Streptococcus
Business Wire about 51 days agoMeridian Bioscience, Inc. today announced it has signed a new group purchasing agreement with the Premier healthcare alliance to offer illumigene® C. difficile and illumigene Group B Streptococcus to its members at specially negotiated pricing.
Meridian Bioscience, Inc. to Release Fiscal 2012 Second Quarter Financial Results on April 26
Business Wire about 51 days agoMeridian Bioscience, Inc. has scheduled the release of its 2012 second quarter financial results for Thursday, April 26 at approximately 7:45 a.m. .
You may also be interested in these VIVO related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| VIVO | 18.91 | -0.03 | -0.16% | 781.28M |
| VIV | 23.69 | +0.07 | +0.30% | 9.007B |
| VITC | 7.54 | -0.15 | -1.95% | 255.54M |
| VIT | 9.00 | -0.18 | -1.96% | 388.50M |
| VIST | 11.30 | -0.01 | -0.09% | 74.53M |
| VISN | 0.98 | +0.02 | +2.08% | 98.16M |
| VGR | 16.42 | -0.18 | -1.08% | 1.319B |
| VGEM | 18.07 | +0.00 | +0.00% | |
| VG | 1.71 | -0.12 | -6.56% | 412.90M |
| VFL | 13.79 | +0.13 | +0.95% |
